Polynucleotides for Hair: What Is Established?

What polynucleotides are

Polynucleotides, often shortened to PN, are molecules made from nucleotides—the building blocks of DNA. Health & Aesthetics gives this definition, while Dr Victoria describes the treatment material as highly purified DNA chains often derived from fish. These are clinic descriptions of the material, not proof that injecting it will improve your hair. For you, the useful starting point is understanding what a clinic is actually offering.

The proposed goal is to support the scalp environment and follicle function. Thérapie Clinic says its formulation stimulates fibroblasts, cells involved in producing collagen, and supports follicle repair. Dr Victoria also claims reduced inflammation and improved tissue hydration. These are clinic mechanism claims. They explain the treatment rationale, but do not establish how much benefit you should expect or who is likely to respond.

For hair treatment, the clinic sources reviewed here describe injections rather than a topical scalp product. Thérapie Clinic offers Plinest Hair as a polynucleotide injectable, while Health & Aesthetics describes injecting PN-rich solutions directly into the scalp. If you are researching “PN hair” products, check the exact formulation and delivery method: the injection study does not establish benefits for a serum or ampoule.

Sources 1, 2, 3, 4

Polynucleotides vs PDRN: what can you compare?

A precise molecular distinction between PN and PDRN is not established by the sources reviewed here. They describe polynucleotides, but provide no PDRN definition or direct PN-versus-PDRN study. That means this page cannot responsibly tell you that PN is stronger, longer-lasting, or more effective. You can read the separate guide to PDRN for hair loss, but the terms should not be treated as evidence of equivalent outcomes.

The clearest distinction in these sources is between named treatments, not between the abbreviations. Thérapie Clinic lists Plinest Hair; the prospective human study used DOT PN. Whether these formulations are interchangeable is not established here. When you discuss a polynucleotide scalp treatment, ask the clinic to name the product and explain which published evidence applies to that particular treatment.

If a clinic presents PN as an upgrade from PDRN, ask for the comparison behind that claim. The prospective study measured outcomes after DOT PN treatment; it does not provide a PN-versus-PDRN result. A shared description involving DNA is not enough to establish comparative effectiveness. For your decision, product-specific evidence matters more than an explanation that makes the treatments sound similar.

Sources 1, 2, 3, 4

How clinics use PN on the scalp

Clinic treatment starts with an assessment, followed by injections into areas with thinning hair. Health & Aesthetics says a doctor evaluates the scalp and hair loss condition before treatment, and lists an appointment length of 30 to 45 minutes. These are clinic practice descriptions, not trial findings. Your consultation should clarify what is causing the thinning before deciding whether an injectable treatment is appropriate.

Treatment schedules differ between the clinic descriptions and the human study reviewed here. Thérapie Clinic lists four sessions separated by 7–14 days and a treatment length of 30 minutes. By contrast, the prospective DOT PN study used four injections at four-week intervals. Neither schedule is established here as the preferred approach. Ask why your clinic recommends its interval and whether that schedule matches the evidence for its product.

Clinics also describe combining PN with other treatments. Dr Victoria says it can be used alongside PRP or topical minoxidil, or after hair transplantation. That is a clinic-use claim, not evidence that adding PN improves the outcome. If you already use either treatment, ask what extra benefit is established; the PRP hair-loss guide can help you separate the options during that discussion.

Timing claims also need context. Thérapie Clinic says results are seen in 4–6 weeks and describes their duration as long-term, but these are clinic claims rather than a defined durability result from the study. Before booking, ask how progress will be measured, when the treatment will be reviewed, and what the clinic means by long-term. A maintenance schedule is not established by the research reviewed here.

Sources 1, 2, 3, 4

What the evidence shows

PN has early human evidence, but the study reviewed here is small. A prospective study evaluated 28 patients with androgenetic alopecia who received DOT PN injections. Researchers measured hair diameter and density using dermoscopy, a magnified examination of the scalp, and collected patient and dermatologist assessments. This is a small prospective human study, not a randomized comparison or meta-analysis establishing how PN performs against other treatments.

The researchers reported significant improvements in hair diameter and total hair density, beginning one month after treatment. Dermatologist assessment indicated stabilization in 60.7% of cases, while patient assessment indicated improvement in 82.1%. Those assessments describe different outcomes and should not be combined into a single success rate. The findings are encouraging, but they do not establish your likelihood of benefit or superiority over PDRN, PRP, or minoxidil.

Related DNA research is not automatically evidence for clinic PN injections. A separate review discusses antisense oligonucleotides—molecules designed to target specific genetic messages—and reports potential effects in mouse models of hair loss. That is animal evidence involving a different therapeutic approach. It should not be used to validate Plinest Hair or DOT PN. The research guide helps you keep human treatment findings separate from laboratory and animal work.

Sources 1, 4, 5

Side effects and who should seek advice first

Mild redness and swelling are reported by clinics, while the small prospective study reported no serious side effects. Health & Aesthetics says redness or swelling typically resolves within a day or two, most patients experience minimal discomfort, and regular activities can usually resume immediately. These clinic reports and small-study findings do not establish that treatment is risk-free or provide a complete picture of uncommon adverse effects.

The sources reviewed here do not provide a complete list of people who should avoid PN injections. Because clinics describe materials often derived from fish, ask about the exact formulation and discuss any relevant allergies with the treating doctor. Do not assume that highly purified means suitable for everyone. Health & Aesthetics also says treatment requires existing hair and will not work on bald patches or total baldness; this is a clinic limitation statement.

See a dermatologist before booking if your loss is sudden or patchy, or you have scarring, pain, itching, scaling, or loss after illness or a new medication. The cause needs confirmation rather than an assumption that PN is appropriate. The review describes alopecia areata as an autoimmune condition characterized by sudden loss, while the PN study evaluated androgenetic alopecia. This page is information, not medical advice.

Sources 1, 2, 3, 4, 5